
Agilent Technologies A
$ 116.92
2.67%
Quarterly report 2025-Q4
added 03-03-2026
Agilent Technologies DPO Ratio 2011-2026 | A
Annual DPO Ratio Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 50.1 | 51.6 | 54.8 | 55.7 | 54 | 46.8 | 51 | 51.2 | 48.6 | 51.7 | 55.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.8 | 46.8 | 51.9 |
Quarterly DPO Ratio Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.8 | - | 57.8 | 63.4 | - | - | - | 54.9 | 63 | - | - | 55.1 | 54.2 | - | 53.6 | 49.9 | 49.1 | 17.9 | 53 | 50.9 | 52.9 | 18.7 | 55.5 | 51.8 | 53.6 | 18.8 | 57.2 | 49.4 | 53 | 18.3 | 53.7 | 49.6 | 47.1 | 15.8 | 46.7 | 48 | 47.7 | 17 | 50.8 | 67 | 67.1 | 18.3 | 54.4 | 68.6 | 50.5 | 16.2 | 49.5 | 46.5 | 53.2 | 17.5 | 50.5 | 50.7 | 59.5 | 18.9 | 53.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 68.6 | 15.8 | 46.5 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
BioNano Genomics
BNGO
|
149 | $ 1.18 | 0.85 % | $ 6.43 M | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.98 | -0.63 % | $ 8.76 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 17.92 | 1.41 % | $ 955 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.24 | 0.93 % | $ 175 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 25.19 | 1.45 % | $ 700 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 175.07 | 3.26 % | $ 8.68 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Danaher Corporation
DHR
|
65.4 | $ 196.19 | 2.71 % | $ 140 B | ||
|
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
57.9 | - | -0.91 % | $ 14.7 B | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 51.17 | 2.09 % | $ 3.06 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 15.83 | -0.5 % | $ 479 M | ||
|
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M | ||
|
Guardant Health
GH
|
48.6 | $ 92.84 | -0.49 % | $ 11.6 B | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 2.73 | 1.49 % | $ 88.6 K | ||
|
Biomerica
BMRA
|
32.4 | $ 2.15 | -0.46 % | $ 4.94 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 106.54 | -0.58 % | $ 8.79 B | ||
|
Illumina
ILMN
|
56.3 | $ 128.0 | 1.23 % | $ 20.4 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 274.72 | 2.06 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 80.03 | 2.5 % | $ 5.4 B | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 520.65 | 2.39 % | $ 15 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 198.81 | 1.02 % | $ 22.1 B | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.77 | 0.63 % | $ 442 M | ||
|
NeoGenomics
NEO
|
19.7 | $ 8.22 | 1.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 10.34 | 3.61 % | $ 2.24 B | ||
|
ENDRA Life Sciences
NDRA
|
1.65 K | $ 5.17 | -3.18 % | $ 4.07 M | ||
|
National Research Corporation
NRC
|
10.1 | $ 17.26 | 1.29 % | $ 386 M | ||
|
Natera
NTRA
|
17.9 | $ 210.83 | 0.75 % | $ 20.7 B |